By continuing to use the site you agree to our Privacy & Cookies policy

MHRA updates advice for osteoporosis drug use

Healthcare professionals treating severe osteoporosis in women who have gone through the menopause and men with a high risk of fracture are to be given updated advice on the use of Protelos.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units